Rpp1, essential protein subunit nuclear RNase P required processing precursor tRNA 35S precursor
rRNA Saccharomyces cerevisiae

 gene essential protein subunit nuclear RNase P Saccharomyces cerevisiae cloned. gene protein, RPP1, identified virtue homology human scleroderma
autoimmune antigen, Rpp30, copurifies human RNase P. Epitope-tagged Rpp1 association RNase P RNA related endoribonuclease, RNase MRP RNA, immunoprecipitates crude extracts cells. Depletion Rpp1 vivo leads accumulation precursor tRNAs unprocessed 5* 3* termini reveals rRNA processing defects described previously proteins associated RNase P RNase MRP. Immunoprecipitated complexes cleave yeast precursor
tRNAs precursor rRNAs.
[Key Words: Rpp1; essential protein subunit; nuclear RNase P; S. cerevisiae; precursor tRNA; precursor rRNA]
Received June 5, 1997; revised version accepted July 25, 1997.




Ribonuclease P (RNase P) ubiquitous endoribonucle-              limited. RNAse P isolated human cells copurifies
ase consists protein RNA subunits. cleaves            RNA (H1; 340), proteins—Rpp14,
58-terminal leader sequences precursor tRNAs (Darr et             Rpp20, Rpp25, Rpp30, Rpp38, Rpp40 (Eder et al.
al. 1992; Altman et al. 1993). Escherichia coli RNase P           1997). Genetic approaches Saccharomyces cerevisiae known process precursors small, meta-               identified essential proteins, Pop1, Pop3, biologically stable RNAs vivo, 4.5S RNA                   Pop4, associate RNase P RNA (RPR1); (Bothwell et al. 1976), 10Sa RNA (Komine et al. 1994),               proteins associate RNA (NME1) related polycistronic mRNA histidine operon (Ali-               endoribonuclease, RNase mitochondrial RNA process-
fano et al. 1994), small RNAs encoded bac-               ing (MRP) (Schmitt Clayton 1992; Lygerou et al.
teriophage (Bothwell et al. 1974; Hartmann et al. 1995).             1994; Dichtl Tollervey 1997; Chu et al. 1997). Analy- eubacteria, RNA component RNase P                 sis temperature-sensitive alleles proteins catalytic vitro (Guerrier-Takada et al. 1983). eu-            depletion proteins yeast cells shown bacterial protein subunit basic protein ∼14 kD           role tRNA processing rRNA
serves essential cofactor vivo enhancing             processing. suggested tRNA rRNA
catalytic efficiency substrate range holoen-              processing coordinated (Pace Burgin 1990; Clay-
zyme (Liu Altman 1994; Gopalan et al. 1997).                  ton 1994; Morrissey Tollervey 1995; Lee et al. 1996).
contrast, RNA components archaeal eukary-                    eukaryotes, coordination tRNA rRNA pro-
otic RNase P catalytically active vitro            cessing mediated activity related
absence respective protein subunits, despite                enzymes, RNase P RNase MRP (Morrissey Tol- structural homology eubacterial RNAs (Alt-              lervey 1995; Chamberlain et al. 1996b). RNase P es-
man et al. 1995; Haas et al. 1996).                                  sential biosynthesis tRNAs (Lee et al. 1991)    RNA subunit nuclear RNase P                   appears role rRNA processing yeast characterized variety eukaryotic organ-               (Chamberlain et al. 1996b). RNase MRP related isms (Altman et al. 1993; Tranguch Engelke 1993;                 RNase P structural similarities RNA
Chamberlain et al. 1996a; Eder et al. 1996), information             component (Forster Altman 1990; Schmitt et al.
regarding protein subunits eukaryotic RNase P              1993). suggested RNase P ancestor
                                                                     RNase MRP (Morrissey Tollervey 1995). RNase
3
 Corresponding author.                                               MRP described originally endonuclease E-MAIL sidney.altman@qm.yale.edu; FAX (203) 432-5713.                cleaves RNA primers mitochondrial DNA replication


2414      GENES & DEVELOPMENT 11:2414–2425 © 1997 Cold Spring Harbor Laboratory Press ISSN 0890-9369/97 $5.00
                                                                              essential protein subunit RNase P yeast



(Chang Clayton 1987; Stohl Clayton 1992).         amino acid sequence identity human Rpp 30 (Fig.
cently, role nuclear processing precursor rRNA     1A). yeast gene named RPP1 RNase P
(prRNA) established (Lygerou et al. 1996a).         Protein 1.
RNase MRP does cleave precursor tRNAS (ptRNAs)             address putative protein encoded vitro, depletion NME1 RNA does affect          RPP1 essential gene, disrupted gene 
tRNA processing vivo (Schmitt Clayton 1993; Ly-       placing LEU2 gene  Materials Meth-
gerou et al. 1996a).  proteins associated       ods). heterozygous RPP1/rpp1::LEU2 strain (VS161) RNase MRP depleted inactivated muta-        sporulated subsequent tetrad analysis showed tion yeast, cleavage ptRNAs blocked (Lygerou et     2:2 segregation cell viability (Fig. 1B). viable
al. 1994; Chu et al. 1997; Dichtl Tollervey 1997).       spores Leu−, indicating wild-type
   learn functions nuclear RNase P      RPP1 allele.  RPP1 essential gene S. vivo, report cloning functional char-     cerevisiae.
acterization essential protein (Rpp1, 32.2 kD) com-
ponent S. cerevisiae RNase P. Rpp1 homologous                                                              Construction epitope-tagged allele RPP1 human scleroderma autoimmune antigen, Rpp30, identified recently protein copurifies   Epitope-tagged proteins useful study subunit human RNase P recognized sera       function interactions large holoenzyme com-
patients autoimmune disease referred      plexes. determine Rpp1 associates
Th antisera (Eder et al. 1997). identify novel func-   RPR1 RNA RNase P activity, epitope-tagged
tions RNase P yeast, strain S. cerevisiae    RPP1 strain S. cerevisiae (VS162) constructed
conditionally expresses Rpp1 protein constructed.        (Table 1). DNA fragment encodes copies Using strain stain contains epitope-      c-myc epitope (3 × myc; TerBush Novick 1996) tagged RPP1 gene, demonstrate role Rpp1          fused frame 38 initiator ATG codon RPP1 processing tRNA ribosomal RNA precursors. Deple-         low-copy-number plasmid (pRS316), pRS316::3 × myc–
tion Rpp1 protein revealed global defects rRNA         RPP1. resulting strain grew identical rates processing. Depletion inactivation proteins associ-    wild-type cells suggesting 3 × myc–RPP1 allele
ated RNase P RNase MRP affect subset       fully functional (Fig. 2A, lanes 2,4). Immunoblots rRNA processing events (Lygerou et al. 1994;        protein extracts 3 × myc–RPP1 cells anti-myc
Chu et al. 1997; Dichtl Tollervey 1997). Based    antibody (9E10) detected polypeptide 36 kD observed defects rRNA processing, suggest pos-       size consistent predicted 3 × myc–
sible functional interaction RNase P RNase           Rpp1 fusion protein (Fig. 2B, lanes 2,4). Wild-type hap-
MRP, small nucleolar ribonucleoprotein (RNP)       loids (VS162A VS162C) lacking c-myc tag complexes (snoRNP; review, Filipowicz Kiss       contain 36-kD protein. results 1993; Fournier Maxwell 1993; Maxwell Fournier        myc epitope-tagged Rpp1 protein migrates 36-kD
1995), required processing prRNA.            polypeptide fully functional.


                                                             RNase P RNase MRP RNAs coprecipitate Results
                                                             3 × myc–Rpp1 fusion protein essential yeast gene encodes homolog                                                              Rpp1 associated RNase P RNA
human scleroderma autoimmune antigen, Rpp30
                                                             determined immunoprecipitation experiments used combination biochemical genetic stud-       (Fig. 3). Extracts 3 × myc–RPP1 RPP1 strains
ies human S. cerevisiae cells characterize       incubated anti-myc monoclonal antibody
protein subunit eukaryotic RNase P. employed           (9E10) RNA extracted immunoprecipi-
computational sequence search yeast genes       tates  Materials Methods). RNA 38 end-
amino acid sequence similarity biochemically identi-      labeled [32P]pCp analyzed denaturing gel
fied human RNase P protein subunits (Eder et al. 1997).      electrophoresis (Fig. 3A,B). Immunoprecipitatd RNA determine proteins associated hu-       analyzed Northern hybridization confirm man RNase P essential components required           identity labeled RNAs (Fig. 3C,D). Mature RNase catalytic function (Eder et al. 1997), searched   P RNA major RNA species 3 × myc–
homologs Rpp14, Rpp20, Rpp25, Rpp30, Rpp38,           Rpp1 precipitate 3 × myc–RPP1 cells Rpp40 genome S. cerevisiae (Goffeau et al. 1996)   control cell lysates. putative precursors performing BLAST search (blastp tblastn algo-       RNase P RNA (Lee et al. 1991) RNase MRP RNA rithms; Altschul et al. 1990) S. cerevisiae genome    immunoprecipitates 3 × myc–RPP1
database (Cherry et al. 1996). human scleroderma         control immunoprecipitates. Approximately
autoimmune antigen, Rpp30, highest amino acid        equal levels RNase P RNase MRP RNAs (RPR1
sequence similarity predicted sequence. previ-        NME1, respectively) end-labeled RNA
ously uncharacterized open reading frame (ORF),              derived immunoprecipitates washed
YHR062c, right arm chromosome VIII         buffer contained 150 mM KCl RNAs (Fig. 3A).
potential encode protein 32.2 kD shares 23        RNase P RNA major RNA species 


                                                                                         GENES & DEVELOPMENT              2415
 Stolc Altman




Figure 1. RPP1, essential yeast gene
encodes 32.2-kD protein ortholog human scleroderma autoimmune antigen,
Rpp30.   Predicted amino acid sequence S. cerevisiae Rpp1. protein 
coded ORF YHR062c chromosome
VIII alignment human
scleroderma autoimune antigen Rpp30 shown. amino acid sequences numbered methionine resi- protein. Identical amino acids shaded similar amino acids boxed. (B) heterozygous diploid strain
VS161, RPP1/rpp1::LEU2, sporulated dissections performed 20 tet-
rads. spores  D) derived tetrads shown vertical
rows.



tected 38 end-labeling RNA 3 × myc–Rpp1 im-               association Rpp1 RNaseP activity munoprecipitates washed buffer           demonstrated immunoprecipitation. Immuno-
tained 60 mM KCl (Fig. 3B).  possible         precipiated  resuspended) 3 × myc–Rpp1 pellets ac-
achieve significant separation enzymes,             curately cleaved radiolabeled ptRNASer (Fig. 4) physically functionally (Lygerou et al. 1996a;          ptRNATyr (data shown) vitro. conclude .                                                  Rpp1 protein component  tightly associated



Table 1.   Strains S. cerevisiae used study

Strain                                                         Genotype

JN161       MATa/MATa ade2-1/ade2-1 leu2-3,112/leu2-3,112 ura3-1/ura3-1 his4-260/his4-260 thr1-4/thr1-4 lys2nNheI/lys2nNheI
VS161       MATa/MATa ade2-1/ade2-1 leu2-3,112/leu2-3,112 ura3-1/ura3-1 his4-260/his4-260 thr1-4/thr1-4 lys2nNheI/lys2nNheI
             RPP1/rpp1::LEU2/RPP1
VS162       MATa/MATa ade2-1/ade2-1 leu2-3,112/leu2-3,112 ura3-1/ura3-1 his4-260/his4-260 thr1-4/thr1-4 lys2nNheI/lys2nNheI
             RPP1/rpp1::LEU2/RPP1 + pRS316–3xmyc::RPP1
VS162A      MATa ade2-1 leu2-3,112 ura3-1 his4-260 thr1-4 lys2nNheI RPP1 + pRS316–3xmyc::RPP1
VS162B      MATa ade2-1 leu2-3,112 ura3-1–his4-260–thr1-4 lys2nNheI rpp1::LEU2 + pRS316–3xmyc::RPP1
VS162C      MATa ade2-1 leu2-3,112 ura3-1 his4-260 thr1-4 lys2nNheI RPP1 + pRS316–3xmyc::RPP1
VS162D      MATa ade2-1 leu2-3,112 ura3-1–his4-260–thr1-4 lys2nNheI rpp1::LEU2 + pRS316–3xmyc::RPP1
VS162A8     MATa ade2-1 leu2-3,112 ura3-1 his4-260 thr1-4 lys2nNheI RPP1
VS162C8     MATa ade2-1 leu2-3,112 ura3-1 his4-260 thr1-4 lys2nNheI RPP1
NY1060      MATa/MATa GAL1/GAL1 leu2-3,112/leu2-3,112 ura3-1/ura3-1
VS163       MATa/MATa GAL1/GAL1 leu2-3,112/leu2-3,112 ura3-1/ura3-1 RPP1/rpp1::LEU2
VS164       MATa GAL1 leu2-3,112 ura3-1 + pYCpGAL::rpp1 (URA3)
VS165       MATa GAL1 leu2-3,112 ura3-1 + pYCpGAL (URA3)



2416       GENES & DEVELOPMENT
                                                                                      essential protein subunit RNase P yeast


  catalytically active RNase P holoenzyme. Indirect
supporting evidence conclusion comes ex-
periments human homolog Rpp1, Rpp30, shown separable active holoen-
zyme extensive biochemical purification (Eder et al.
1997).


Construction conditional lethal allele RPP1
RPP1 placed control GAL10 pro-
moter, allows expression gene culture
medium contains galactose suppresses expres-
sion culture medium contains glucose. 
sulting strain, rpp1::LEU2–pGAL::rpp1 (VS164), compared phenotype control strain RPP1–pGAL
(VS165). liquid culture contained galactose, difference growth rate GAL::rpp1
strain wild-type RPP1 strain. cultures transferred medium contained glucose, cell
growth continued initially doubling time 2 hr. 12–16 hr, growth rate GAL::rpp1 strain




                                                                    Figure 3. RNA subunits RNase P (RPR1) RNase
                                                                    MRP (NME1) coprecipitate 3 × myc–Rpp1.   Immuno-
                                                                    precipitated RNAs extracted 9E10 Ab–IgG–agarose
                                                                    beads incubated protein extracts                                                                     spores (VS162A8, VS162B, VS162C8, VS162D; lanes 1–4, 
                                                                    spectively). RNA extracted immunoprecipitated
                                                                    beads washed 150 mM KCl  Materials                                                                     Methods). RNA 38 end-labeled [58-32P]pCp,                                                                     fractionated 8  polyacrylamide/7 M urea gel. (B) Immu-
                                                                    noprecipitated RNAs derived immunoprecipi-
                                                                    tated beads (lanes 1–4, respectively)                                                                     immunoprecipitated beads washed 600 mM KCl prior
                                                                    38 end-labeling RNA. (C) Immunoprecipitated RNAs
                                                                    derived immunoprecipitated beads                                                                     transferred positively charged nylon membrane (Boehringer
                                                                    Mannheim) electroblotting hybridized uniformly
                                                                    labeled DNA probe complementary RPR1 gene  Ma-
Figure 2. 3 × myc–Rpp1 functional recognized 9E10         terials Methods). (Lanes 1–4) Immunoprecipitated RNA
antibody.   spores (VS162 D; lanes 1–4, respec-        spores VS162A8, VS162B, VS162C8, VS162D, respec-
tively) derived diploid strain VS162, dissected    tively; (lane 5) RNA supernatant immunoprecipi-
rich medium plates (YPAD), replica-plated plates      tated extract derived spore VS162A8 centrifugation contained synthetic complete medium lacked         beads; (lane 6) RNA supernatant immunoprecipi-
leucine (leu) uracil (ura), contained 5-FOA. (B) Immu-   tated extract derived spore VS162B centrifugation noblot protein extracts prepared spores            beads; (lane 7) RNase P (RPR1) RNase MRP (NME1) RNAs
VS162A8, VS162B, VS162C8, VS162D, derived dip-         (0.001 pmoles  transcribed vitro. small arrows
loid strain VS162. spores isogenic          point extended species, precursors mature
VS162A8 VS162C8 spores pRS316–3 × myc–          RNase P RNA, RPR1 (Lee et al. 1991). larger arrows indi-
Rpp1 plasmid. (Lanes 1–4) VS162A8, VS162B, VS162C8,             cate RNase P (RPR1) RNase MRP (NME1) RNAs. (D) VS162D, respectively. arrowhead points 36-kD             C, membrane hybridized uniformly
3 × myc–Rpp1 fusion protein. upper band nonspecifi-        labeled DNA probe complementary NME1 gene (Schmitt
cally reacting protein.                                             Clayton 1992).


                                                                                                 GENES & DEVELOPMENT              2417
 Stolc Altman



                                                                 declined rapidly little growth 16 hr
                                                                 (Fig. 5A).


                                                                 Rpp1 required processing ptRNA
                                                                 determine effects Rpp1 depletion bio-
                                                                 synthesis metabolically stable RNAs, total RNA                                                                  isolated GAL::rpp1 strain (VS164) RPP1
                                                                 strain (VS165) various times growth glucose-
                                                                 containing medium. RNA samples VS164                                                                  compared VS165 denaturing gel
                                                                 stained ethidium bromide Northern hybrid-
Figure 4. RNase P activity coprecipitates 3 × myc–Rpp1.     ization.
  IgG–agarose pellets, bound immunoprecipitated      effect Rpp1 depletion accumulation RNase P RNA, derived immunoprecipitates           precursor tRNAs shown Figure 5B. RNAs spores VS162A8, VS162B, VS162C8, VS162D  Fig.     began accumulate 7 hr transfer glucose-
3B), incubated uniformly labeled precursor tRNASer   containing medium. time, culture growth 30 min 37°C, fractionated 8  polyacryl-
                                                                 began slowed significantly. abundance amide/7 M urea gel  Materials Methods). (Lane 1) Pre-
                                                                 RNAs increased time sizes appro-
cursor tRNASer; (lanes 2–5) immunoprecipitated RNase P spores VS162A8, VS162B, VS162C8, V6S162D,        priate ptRNAs. abundance mature tRNAs 
spectively; (lane 6) glycerol gradient-purified human RNase P,   creased accordingly. Analysis Northern hybridization
fraction F29 (Eder et al. 1997). Arrows indicate ptRNA, accu-    using probes complementary tRNALeu3 (Fig. 5C), rately processed mature tRNA, 58 leader sequence.            intervening sequence (IVS) (data shown) 58 leader




Figure 5. RNase P required processing ptRNA 5.8S rRNA vivo.   Growth strain VS164 (j), wild-type, isogenic strain
VS165 (h), transfer galactose-containing glucose-containing medium T = 0. Cell den-
sity measured times indicated cultures diluted glucose-containing 
dium time point prevent nutritional 
pravation maintain exponetial growth. (B)
RNA extracted VS164 following growth glucose-containing medium indicated
times, fractionated 8  polyacryl-
amide/7 M urea gel, stained ethidium
bromide. positions 5.8S (L) RNA, 5.8S (S)
RNA, 5S RNA, ptRNA, mature tRNA 
dicated. (C) Total RNA extracted VS164 VS165 transferred positively charged ny-
lon membrane (Boehringer Mannheim) electro-
blotting hybridized g-32P-labeled oligo-
nucleotide complementary mature tRNALeu
 Materials Methods). position processing intermediates ptRNA indicated. PT primary transcript, extra sequences termini contains intron; IVS ptRNA contains 
tron processed 58 38
ends; 58 38 spliced ptRNA unpro-
cessed termini. (D) Steady-state levels RNase P RNA (RPR1) RNase MRP RNA
(NME1) VS164 transfer galactose-
containing glucose-containing medium.  band RPR1 panel putative precur-
sor RPR1 RNA extra sequences termini (Lee et al. 1991). U6 snRNA levels detected oligo U6 (Table 2), internal
control RNA levels (Brow Guthrie 1990).


2418      GENES & DEVELOPMENT
                                                                               essential protein subunit RNase P yeast



sequence pre-tRNALeu3 (data shown), showed         mature precursor RPR1 RNAs NME1 RNA accumulation tRNA unprocessed          reduced (Lygerou et al. 1996a; Chu et al. 1997; Dichtl
termini. growth GAL::rpp1 strain glucose      Tollervey 1997). data suggest 12 hr, 58 38 unprocessed ptRNALeu3 accumulated        Rpp1 correlated maturation stability approximately level mature tRNA.       RPR1 stability NME1 vivo. RNAs level pre-tRNALeu3 unspliced pro-         large RNP complex, alternatively,
cessed 58 end reduced correspondingly.       Rpp1 shared RNP particles results showed sequentially ordered removal       vivo. 58 leader sequence, 38 trailing sequence, fi-
nally intron ptRNALeu3, impaired Rpp1 
pleted cells. phenotype observed RNase      Rpp1 required processing 35S prRNA
P RNA mutants, rpr1 rpr1 (T315DT307) (Lee et al.          S. cerevisiae eukaryotes, rRNA tran-
1991; Chamberlain et al. 1996b), conclude Rpp1        scribed 35S precursor RNA contains essential protein subunit catalytically active   sequences rRNA molecules (18S,
RNase P complex vivo.                                      5.8S, 25–28S). Subsequent processing nucleotide
                                                              modifications involving endonucleolytic exonucleo-
                                                              lytic cleavages methylation generate mature rRNA
Rpp1 required accumulation RNase P                                                                review, Eichler Craig 1994; Venema Tol-
RNase MRP RNAs
                                                              lervey 1995; Tollervey 1996). examined fidelity investigated effect Rpp1 depletion       rRNA processing Rpp1-depleted cells determine steady-state levels RNase P RNase MRP              defects pathway similar described
RNAs ascertain cells lacking Rpp1 shared pheno-         previously mutants affect RNase P RNase
typic traits previously described conditional lethal     MRP (Shuai Warner 1991; Lindahl et al. 1992;
mutants Pop1, Pop3 Pop4, proteins associate       Schmitt Clayton 1993; Chamberlain et al. 1996b; RNPs. Depletion Rpp1 results decrease       Lygerou et al. 1996a; Chu et al. 1997; Dichtl Toller- steady-state levels RNaseP RNase MRP            vey 1997). rRNAs analyzed gels stained RNAs (Fig. 5D).  RPR1 RNA precursor does          ethidium bromide Northern analysis oligo- appear decrease extent mature           nucleotide probes (Table 2) detect various prRNA spe-
RPR1 RNA, 30 hr Rpp1 depletion.         cies  Figs. 5B 6).
Pop4 depletion (Chu et al. 1997), mature RPR1 RNA             depletion Rpp1 protein, observed mul- detectable 21 hr Rpp1 depletion. contrast,    tiple defects rRNA processing A0 A1 sites
depletion Pop3 does affect steady-state levels      58 external transcribed sequence (58 ETS), RNAs, pop1-1 steady-state levels          A2 A3 sites internal transcribed sequence



Table 2.   Oligonucleotides used study

Oligo   1: 58-CAGCAGAGAGACCCGA-38
Oligo   2: 58-ACTATCTTAAAAGAAGAAGC-38
Oligo   3: 58-GAATTACCACGGTTATACC-38
Oligo   4: 58-GCACAGAAATCTCTCACC-38
Oligo   5: 58-ATGAAAACTCCACAGTG-38
Oligo   6: 58-CCAGTTACGAAAATTCTTG-38
Oligo   7: 58-CGCATTTCGCTGCGTTCTTCATCG-38
Oligo   8: 58-ACAGAATGTTTGAGAAGGAAATG-38
Oligo   U6: 58-TCATCCTTATGCAGGG-38
Oligo   mtRNA: 58-GCATCTTACGATACCTG-38
Oligo   ltRNA: 58-CCAAACAACCACTTATTTGTTGA-38
Oligo   itRNA: 58-CACAGTTAACTGCGGTC-38
Oligo   T7MRP: 58-GGGAATTCGAAATTAATACGACTCACTATAGAATCCATGACCAAAGAATCGTCA-38
Oligo   38 MRP: 58-TCCCCCGGGTGAATCCATGGACCAAGA-38
Oligo   T7ITS14: 58-GGGAATTCGAAATTAATACGACTCACTATAGACACTGTGGAGTTTTCATATC-38
Oligo   38 ITS14: 58-GGGGATCCTTAAAATTTCCAGTTACGAAAATTC-38
Oligo   T7ITS16: 58-GGGAATTCGAAATTAATACGACTCACTATAGGCCAAACGGTGAGAGATTTCTG-38
Oligo   38 ITS16: 58-GGGGATCCACTTTAAGAACATTGTTCGCCT-38
Oligo   MYC5: 58-GCGGAATGCTGGAACAGAAACTTATT-38
Oligo   T7ITS16: 58-GGGAATTCGAAATTAATACGACTCACTATAGGCCAAACGGTGAGAGATTTCTG-38
Oligo   38 ITS16: 58-GGGGATCCACTTTAAGAACATTGTTCGCCT-38
Oligo   MYC3: 58-ACCAGCATTCCCAAATCTTCTTCAGA-38
Oligo   5 GAL30: 58-GGGGATCCGCATTATAGAACCGAGAATGC-38
Oligo   3 GAL30: 58-GGTCTAGAGATCCCCAAATTTTTTTGTCT-38



                                                                                          GENES & DEVELOPMENT              2419
 Stolc Altman



                                                                      A3 site ITS1 processing sites
                                                                      required maturation 5.8S rRNA vivo (Schmitt
                                                                      Clayton 1993; Henry et al. 1994). Figure 6, C D,
                                                                      shows accumulation 7S precursor 5.8S rRNA
                                                                      7 hr Rpp1 depletion. precursor predicted
                                                                      58 end A2 site ITS1 38 end                                                                       38 end 5.8S rRNA. prediction proven
                                                                      correct, able conclude                                                                       defect cleavage A3 site conditions                                                                       used.
                                                                         addition, large precursors 18S rRNA ac-
                                                                      cumulated later times Rpp1-depleted cells (Fig.
                                                                      6C,D). 24S rRNA precursor contains 58
                                                                      ETS ITS1 sequences shows defects cleavage                                                                       A0, A1, A2, A3 processing sites, 21S rRNA
                                                                      precursor shows defects cleavage processing                                                                       A2 A3 processing sites ITS1 E site                                                                       ITS2 (Fig. 6C,D). 17S 12S rRNA degradation
                                                                      intermediates represent sequences fragmented 58
                                                                      ends 18S rRNA (Fig. 6C,D; Allmang et al.
                                                                      1996a). Figure 6E shows depletion 7S(S) 7S(L)
Figure 6. Processing prRNA Rpp1 immunoprecipitates.             precursors 5.8S(S) rRNA, depletion 27SA   Position ITS141 rRNA substrate relative 35S         27SB precursors 25S rRNA, accumulation 8S
rRNA precursor [58 end A2 site 38 end B1(L) site].    rRNA precursor 5.8S rRNA, contains 58
(B) Uniformly labeled rRNA transcript, ITS141  Materials          extended sequences ITS1 38 extended se- Methods), incubated 3 × myc–Rpp1 immunopre-              quences ITS2. intermediates indicate defects
cipitates derived immunoprecipitates Fig.         cleavage A3, E C2 processing sites 3A 2 hr 37°C, fractionated 8  polyacryl-         ITS1 ITS2, respectively. probes detected
amide/7 M urea gel. (Lanes 1–4) ITS141 rRNA, plus IgG–agarose
                                                                      moderate accumulation 35S rRNA primary tran-
pellets bound immunoprecipitated RNase P RNase MRP RNAs, respectively, Fig. 3A. (Lane 5) ITS141
                                                                      script probes 2–7 detect 32S precursor rRNA
rRNA. arrow indicates position cleavage prod-          (Fig. 6C–E; data shown). Despite defects ucts identical size ITS1 rRNA transcripts.         steady-state levels 18S rRNA 25S rRNA  site cleavage corresponds region A3 site      mained unchanged (Fig. 6B), suggesting delayed process- internal transcribed sequence 1 (ITS1) (Lygerou et al. 1996).     ing 35S rRNA absence Rpp1.
                                                                         results Rpp1 required processing
                                                                      35S rRNA 58 ETS, ITS1, ITS2. Interestingly,
(ITS1), E C2 sites internal              processing reactions shown
transcribed sequence 2 (ITS2) (Fig. 6). Analysis low-              dependent snoRNPs, RNase MRP, RNase P,
molecular-weight RNA showed synthesis 5.8S(S)                 stable rRNA degradation intermediates ac-
rRNA reduced Rpp1-depleted strain,                  cumulate cells deficient snoRNP components
5.8S(L) rRNA increased (Fig. 5B). altered ratio                (Shuai Warner 1991; Lindahl et al. 1992; Chamber-
tween 5.8S(L) 5.8S(S) suggests defect cleavage            lain et al. 1996b; Venema Tollervey 1996). 



Figure 7. Effects Rpp1 depletion processing 35S prRNA.   Schematic plan rRNA processing pathway (Venema Tollervey 1995). Steady-state levels rRNA, prRNA intermediates, aberrant rRNA species detected ethidium
bromide staining Northern hybridization oligonucleotide probes 1–7. (B) Total RNA extracted VS164 VS165 obtained transfer galactose-containing glucose-containing medium times indicated, separated l.2  agarose
gel stained ethidium bromide. Arrows indicate 25S rRNA, 18S rRNA, 5.8S rRNA, tRNAs. (C–E) gel shown B transferred positively charged nylon membrane (Boehringer Mannheim) capillary diffusion hybridized g-32-labeled
oligonucleotide probes 4–6  Materials Methods). Oligonucleotide 4 (C) complementary ITS1, 38 end 18S
rRNA A2 site (position 157–180), oligonucleotide 5 (D) complementary ITS1, A2 A3 sites (position
119–236), oligonucleotide 8 (E) complementary ITS2, 38 end 5.8S rRNA C2 sites (position −3 +21). 24S precursor rRNA predicted extend 58 end ETS 38 end 5.8S rRNA, represents product 35S rRNA precursor cleaved ITS2 absence cleavage A0, A1, A2, A3 sites. 21S precursor rRNA appears comprised rRNA species predicted extend 58 end 18S rRNA 38 end 5.8S rRNA, 38 ends extend 38 38 end 5.8S rRNA, heterogeneous. 208S rRNA species predicted extend 58 end 18S rRNA region A3 site ITS1. 17S8 12S8 aberrant rRNA species represent stable degradation
intermediates, fragmented 58 ends correspond sequences 18S rRNA 38 ends close 38 end 5.8S rRNA. 8S rRNA species predicted extend 58 end ITS1 38 extended ends 5.8S rRNA. 7S RNA precursor 5.8S rRNA, predicted extend region A2 site ITS1 38 end 5.8S rRNA.


2420      GENES & DEVELOPMENT
                                                                                   essential protein subunit RNase P yeast


 known proteins associate          sults striking similarities Rpp1-depleted cells RNP particles exhibit global defects prRNA        respect defects prRNA processing (Venema Tol- ptRNA processing Rpp1-depleted cells.         lervey 1996; Discussion).  suggest terestingly, depletion snoRNP protein, Rrp5,        RNase P interacts functionally RNase MRP 



                                        Figure 7.  facing page legend.)


                                                                                              GENES & DEVELOPMENT              2421
 Stolc Altman


 snoRNPs processing rRNA           Rpp1 significantly high-salt washes. 
yeast.                                                        human Rpp30 does associate RNase
                                                             MRP (N. Jarrous S. Altman, unpubl.) yeast
                                                             RNase P cleaves prRNA substrates directly vivo Processing precursor rRNA Rpp1
                                                             unknown. Proposals secondary structure ITS1
immunoprecipitates
                                                             based phylogenetic analysis chemical tested Rpp1 associated directly           mapping ITS1 (Van Nues et al. 1994; Allmang et al.
prRNA processing activity vitro cleavage assay      1996b) computational folding ITS1.141 fragments 35S rRNA. assayed cleavage        prRNA substrate, common structural fea-
vitro resuspended 3 × myc–Rpp1-containing immu-           ture RNase P substrate  helical segment noprecipitates fragments 35S precursor         junction single-stranded region; Altman et al. 1995).
rRNA, ITS1.603 (Chamberlain et al. 1996b) ITS1.141        prRNA substrates used study (similar Lygerou et al. 1996a). prRNA substrates     cleaved A3 site vitro reconstituted E. coli
overlap ITS1  Fig. 7A, Materials Meth-       RNase P (V. Stolc S. Altman, unpubl.), ods). Rpp1 immunoprecipitates, contained          broader substrate specificity eukaryotic RNase
RNase P RNase MRP RNAs, cleaved ITS1.141 (Fig.           P (Yuan Altman 1994).  vivo, yeast
7B) ITS1.603 (data shown) region A3    Rpp1 shared subunit large RNP complex
processing site. result consistent  does    containing RNase P RNase MRP, rigorously prove, observed defects processing     snoRNPs. 35S rRNA depletion Rpp1 protein vivo.         depletion Rpp1 vivo, defect  3 × myc–Rpp1 immunoprecipitates           ptRNA processing, indication Rpp1 associated
washed extensively high ionic buffer  Material      RNase P activity. Surprisingly, Methods) failed cleave prRNA substrates       rRNA processing defect characterized absence cleaved ptRNAs vitro (data shown). results      cleavage A0 A1 sites 58 ETS, suggest addition RNase MRP, direct     A2 A3 sites ITS1, E C2 sites role RNase P-containing complex rRNA pro-          ITS2 primary 35S rRNA transcript. knowl-
cessing vivo.                                             edge, Rpp1 RNase P RNase MRP protein,
                                                             depletion simultaneously inhibits cleavages                                                              major processing sites 35S rRNA Discussion
                                                             required ptRNA processing.  processing cloned gene encoding protein subunit          prRNA sites A0, A1, A2, A3, E, C2 nuclear RNase P S. cerevisiae based homol-       coordinated RNase P, depletion RNase MRP
ogy human Rpp30. Yeast Rpp1 homologous          RNA results defects A3 site (Schmitt
human scleroderma autoimmune antigen, Rpp30,           Clayton 1993). described previously autoantigen copuri-         Apart RNase MRP, essential snoRNPs fies Rpp protein subunits     involved directly mechanism rRNA process-
human RNase P—Rpp14, Rpp20, Rpp25, Rpp30, Rpp38,             ing  recent reviews, Eichler Craig 1994; Ven- Rpp40 (Eder et al. 1997). Using database        ema Tollervey 1995; Tollervey 1996). contrast searches (blastp tblastn algorithms), compared        Rpp1 phenotype, depletion- temperature-sensitive predicted amino acid sequences human Rpp pro-         alleles snoRNAs associated proteins
teins S. cerevisiae genome database. analy-    defect ptRNA processing  ex-
sis revealed Rpp1 yeast proteins   ception snoRNP protein Rrp5, single component amino acid sequence similarity human Rpp pro-         defective processing processing sites teins. second yeast protein Pop4, subunit     58 ETS, ITS1, ITS2. example, Gar1p, Nop1p,
yeast RNase P RNase MRP (Chu et al. 1997),         Sof1p, snoRNA U3, U14, snR30-depleted related amino acid sequence previously unchar-    cells, strains lacking snR10 defective A0, A1,
acterized human Rpp protein, Rpp29 (P. Eder, N. Jarrous,     A2 sites detectable inhibition A3 site S. Altman, unpubl.). yeast, protein, Rpp2,     (Tollervey 1987; Li et al. 1990; Hughes Ares 1991;
shares amino acid similarity Rpp20 (V. Stolc S.     Tollervey 1991; Girard et al. 1992; Jansen et al. 1993;
Altman, unpubl.)                                             Morrissey Tollervey 1993). prRNA processing
   Rpp1 small basic protein predicted molecu-    phenotype Rrp5-depleted strains differs lar mass 32.2 kD pI 9.76. does        Rpp1 defective maintaining accumulation
previously identified RNA-binding domains. vitro,         25S rRNA, 18S rRNA, relative levels rRNA
Rpp1 remains associated mature RNase P RNA          intermediates (Venema Tollervey 1996).  RNase P activity, buffers high ionic          ingly, Rpp1-depleted cells, cleavage A3 site strength. Rpp1 associates RNase MRP RNA            defective Pop1, Pop3, Pop4, RNase MRP rRNA processing activity (cleavage A3          (NME1) conditional mutants (Shaui Warner 1981;
site), ascribed previously RNase MRP (Lygerou et al.      Lindahl et al. 1992; Schmitt Clayton 1993; Lygerou
1996a).  contrast RNase P, RNase MRP           et al. 1996a; Chu et al. 1997; Dichtl Tollervey 1997).
RNA rRNA processing activity separated         contrast Rpp1, direct role Pop1 

2422      GENES & DEVELOPMENT
                                                                                        essential protein subunit RNase P yeast



catalysis ptRNAs unknown, human Pop1                    BamHI sites pUC19 (New England Biolabs). generate
homolog (Lygerou et al. 1995b) highly                rRNA ITS1 substrate, ITS1.603 (Chamberlain et al. 1996b), oli-
purified human RNase P (Eder et al. 1997; N. Jarrous             gonucleotides T7ITS16 38 ITS16 used PCR amplify
S. Altman, unpubl.).  Rpp1 shares                 yeast genomic DNA amplified fragment subse-
                                                                     quently subcloned pUC19 way ITS1.141
rRNA processing defects known RNase P, RNase
                                                                     fragment. NME-coding sequence amplified PCR
MRP, snoRNPs, described protein                                                                      yeast genomic DNA using T7MRP 38 MRP oligo- ptRNA processing defect rRNA pro-                nucleotides, subcloned EcoRI SmaI sites pUC19
cessing defects A0, A1, A2, A3, E, C2              generate pUCT7MRP.
processing sites.
                                                                     Strain construction
Materials methods                                                diploid strain heterozygous RPP1 deletion (VS161)
Strains, media, general procedures                               transformed pRS316::3 × myc–Rpp1 plasmid                                                                      sporulated. sporulation dissection, spores disrupted
S. cerevisiae strains used work listed Table 1.   RPP1, harboring plasmid encoded 3 × myc–Rpp1 fu-
composition media appropriate nutrients plas-        sion protein, viable. haploid cells (VS162A8 mid maintenance S. cerevisiae growth handling tech-          VS162C8), derived sporulation single tetrad, vi-
niques used described (Guthrie Fink 1991). Unless        able loss pRS316–3 × myc–RPP1 plasmid stated  techniques manipulating DNA, RNA,          selection plates contain 5-fluoro-orotic acid (5-FOA): oligonucleotides performed according standard pro-       haploids Leu−, showing lost cedures (Sambrook et al. 1989). identities constructs     pRS316–3 × –RPP1 plasmid wild-type RPP1 allele. verified sequence analysis. Oligonucleotides used         haploids (VS162B VS162D) viable study listed Table 2.                                    pRS316–3 × myc–RPP1 plasmid selection                                                                      5-FOA plates Leu+, showing Gene disruption                                                      3 × myc–tagged RPP1 allele. results obtained
                                                                     dissection additional tetrads. growth rate genomic clone spanning RPP1 locus identified using         haploid rpp1:LEU2 cells (VS162B VS162D), depend S. cerevisiae Genome Database (SGD) obtained        low-copy-number episomal plasmid encoding 3 × myc–
American Tissue Culture Collection (ATCC) cosmid 8025.            RPP1 (pRS316–3 × myc–RPP1) viability, identical Clone 8025 sequenced previously (Johnston et al. 1994).        wild-type haploid cells (VS162A VS162C).
1.4-kb BamHI–XbaI fragment encoding RPP1 gene sub-             VS163 transformed pYCp–GAL::rpp1 plasmid
cloned cosmid 8025 pBluescript (SK) vector (Strata-        (VS164) control plasmid, pYCp–GAL (VS165), sporulated
gene) cut BamHI–XbaI generate pRPP1SK. RPP1              germinated medium contained galactose. vi-
gene disrupted replacing 0.6-kb NcoI–NdeI fragment          able spores obtained independent tetrads LEU2 gene, deleting 65  coding se-           presence plasmid-encoded GAL::rpp1 fusion gene quence. rpp1::LEU2 construct integrated RPP1          verified ura− leu− plates containing galactose.
genomic locus diploid strain JN161 (VS161) correct 
placement allele verified PCR digest analysis:
                                                                     Immunoprecipitation
Oligonucleotides 5GAL30 3GAL30 used amplify
genomic DNA isolated VS161, resulting PCR-amplified             Extracts prepared lysis yeast cells (25 ml,
fragment (2.7 kb) encoding LEU2 flanking sequences            OD600 = 0.5) glass beads (Guthrie Fink 1991). Extracts
Rpp1 mapped restriction enzymes. heterozygous           clarified centrifugation times 15,000g 10
RPP1/rpp1::LEU2 strain (VS161) sporulated tetrad             min. final supernatants used immunoprecipitations
analysis showed 2:2 segregation cell viability. Dissections    adding 4 µg 9E10 antibody protein extract derived performed 20 tetrads. disruption analysis       spores VS162A8, VS162B, VS162C8, VS162D,  performed strain VS163, disrupted         cubated 2.5 hr, followed addition 50 µl 100 mg/ml rpp1::LEU2 construct.                                                anti-mouse IgG  molecule) agarose (Sigma) IP150
                                                                     buffer (150 mM KCl, 10 mM Tris-Cl (pH 7.9), 0.1  NP-40,                                                                      0.1  NaN3). Pellets washed times IP150 Construction expression plasmids
                                                                     IP600  composition IP150, 600 mM KCl). RNA generate myc-epitope-tagged RPP1, myc epitope            extracted immunoprecipitated beads adding
mains (3 × myc) PCR-amplified 3 × mycSEC8              100 µl IPR buffer (100 mM Tris-Cl pH 7.5, 100 mM EDTA
construct (TerBush Novick 1996) using oligonucleoitdes           pH 8.0, 150 mM NaCl, 1  SDS), followed extractions
MYC5 MYC3, cut BsmI. PCR fragment              phenol extraction phenol/chloroform/iso- subcloned BsmI site pRPP1SK plasmid gen-          amylalcohol solution (25:24:1). RNA precipitated erate p3 × myc–RPP1SK. 1.5-kb BamHI–XbaI fragment             ethanol.
p3 × myc–RPP1SK subcloned pRS316 plasmid gen-
erate pRS316–3 × myc::RPP1. coding sequence RPP1                                                                      Assays RNase P activity rRNA processing activity
PCR-amplified pRPP1SK using oligonucleotides 5GAL30 3GAL30, cut BamHI XhoI, subcloned              IgG–agarose pellets, bound immunoprecipitated
modified pYCp33 vector contained GAL1–10 promoter           RNase P RNase MRP RNAs, washed IP150 generate pYCp–GAL::rpp1. generate rRNA ITS1 substrate,         incubated labeled ptRNASer (Tollervey et al. 1991) 30
ITS1.141 (similar Lygerou et al. 1996a), oligonucleotides         min 37°C 1× BB (10 mM HEPES pH 8.0, 400 mM
T7ITS14 38 ITS14 used PCR-amplify yeast genomic          NH4OAc, 10 mM Mg2OAc, 5  glycerol). rRNA transcripts
DNA 141-bp fragment cloned EcoRI           ITS1.141 ITS603 (Chamberlain et al. 1996b) incubated


                                                                       
 IgG-pellets bound immunoprecipitated             
RNase P RNase MRP RNAs (washed IP150) 2 hr               
37°C 1× PMB (20 mM Tris-HCl pH 8.0, 10 mM MgCl2, 1 mM              
EDTA, 50 mM KCl, 2 units RNasin, 50 mg/ml BSA).           
IgG pellets, bound RNase P RNA, washed          
IP600 incubated ptRNASer, ITs141, ITS603           tRNA substrate, ITS141, ITS603 rRNA sub-               
strates labeled uniformly [32P]GTP (3000 mCi/                  
mmole, Amersham) purified 8  polyacrylamide/7 M                 
urea gel. assays performed 0.5 nM ptRNA, 3.2 nM        
ITS141 RNA, 0.5 nM ITS603 RNA. RNA products               
fractionated 8  polyacrylamide/7 M urea gel.                 
RNA analysis                                                           
Total RNA isolated disruption cell pellets (25 ml,         
OD600 = 0.5), resuspended AE buffer [50 mM NaAc pH 5.3,           
10 mM EDTA, 10 mNM RNase inhibitor, vanadyl ribonucleoside             
complex (GIBCO BRL)] equal volume phenol chlo-              
roform, glass beads 65°C 15 min. Phenol/chloroform    
extractions repeated times 65°C 15 min, fol-  
lowed extraction chloroform 25°C ethanol            
precipitation. Northern hybridization performed             
scribed previously (Guerrier-Takada et al. 1995). oligo-          
nucleotides end-labeled T4 polynucleotide kinase              
(New England Biolabs) [g-32P]ATP (Amersham). NME1                   
EcoRI–SmaI DNA fragment pUCT7MRP EcoRI–SmaI                    
DNA fragment pScRNAP (Lee et al. 1991) labeled              
uniformly [32P]dCTP (Amersham).                                    
 